...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Tada
3
Apr 21, 2020 12:21PM
2
Apr 21, 2020 04:13PM
1
Apr 22, 2020 09:40AM
2
Apr 22, 2020 10:46AM
1
Apr 22, 2020 11:00AM
3
Apr 22, 2020 11:10AM
6
Apr 22, 2020 12:03PM
6
Apr 22, 2020 01:43PM

Yes the thread was started here for Zenith.I was speaking To DM on RVX when I asked about the Prostate trial results as was told they expected to present the end of April.Then out of the blue he gave me those numbers on the Breast cancer trial.As I said before all the chaos of C19 I did not post that news at that time for various reasons.Wether the results continued to be stellar I have no idea.Having personally seen a drug work for several scans then fade I am only hopeful that having extended life for prostate patient

Ts and now Breast cancer Zen 3694 will be a blessing in the fight against theses cancers

2
Apr 22, 2020 02:33PM
6
Apr 22, 2020 02:48PM
Share
New Message
Please login to post a reply